SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-17-011698
Filing Date
2017-11-09
Accepted
2017-11-09 17:26:08
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs32017_citiuspharma.htm S-3 426164
2 OPINION OF WYRICK ROBBINS YATES & PONTON LLP fs32017ex5-1_citiuspharma.htm EX-5.1 28958
3 CONSENT OF WOLF & COMPANY, P.C. fs32017ex23-1_citiuspharma.htm EX-23.1 1532
4 GRAPHIC img001.jpg GRAPHIC 16483
5 GRAPHIC sign.jpg GRAPHIC 6351
6 GRAPHIC image_001.jpg GRAPHIC 2839
  Complete submission text file 0001213900-17-011698.txt   493575
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-221492 | Film No.: 171192076
SIC: 2834 Pharmaceutical Preparations